About Johnson & Johnson Innovative Medicine
J&J Innovative Medicine is a leading global pharmaceutical company, part of the Johnson and Johnson group. The J&J IM global planning and customer management organization controls an end-to-end (E2E) global network of manufacturing sites, distribution locations, and affiliates.
The challenge
After a global process concept design and organizational planning re-design the organization was ready for the next mile in their global planning transformation program: implementation of an advanced planning system (APS). The key focus of the APS implementation in terms of business objectives was to increase planning visibility and E2E connectivity, enable planning efficiencies, and optimize inventory.
The project
EyeOn supported the design, implementation, and operationalization of OMP Unison Planning™ for the upstream drug substance supply network of JNJ (a total of 11 sites). The expert team of EyeOn consecutively led detailed process design, user requirements definition, master data design, agile testing, training, go-live support, and handover to the business.
Results
- Successful go-live, operationalization, and embedding of OMP Unison Planning™ with the operational and tactical planning cycles.
- A system capable of dealing with complex planning constraints.
- Realization of the business case in terms of planning efficiency and inventory savings.
Ready to increase planning visibility and E2E connectivity?
Get in touch with us to learn how EyeOn can help you with refining and improving functionalities, expert knowledge on data configuration and hands-on implementation, training and adoption support. We take the extra mile to operationalize your planning cycles and continuously improve your APS experience. EyeOn expert, Bart Paridaen is available to provide personalized guidance and support.